Avapag 20 mg (Avatrombopag) is a thrombopoietin receptor agonist used to treat thrombocytopenia in chronic liver disease and immune thrombocytopenia. It increases platelet production. Common side effects include headache, fatigue, and nausea. Regular blood monitoring is required. Use under medical supervision. https://oncologymedi.com/product/avapag-20-mg-avatrombopag/